The anti-tumor activity of an anti-CD39 antibody (ES002) in a multiple myeloma model is dependent on NK cells

被引：0
|
作者：
Qiu, Yangsheng [1 ]
Du, Qinglin [1 ]
Sun, Meiling [1 ]
Gao, Rui [1 ]
Kong, Huimin [1 ]
Xing, Roumei [1 ]
Shi, Yufei [1 ]
Xu, Mengying [1 ]
Wu, Zhihao [1 ]
Lu, Hongtao [1 ]
机构：
[1] Elpisci Biopharma, Shanghai, Peoples R China
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P790
引用
收藏
页数：1
相关论文
共 50 条
  • [21] ANTI-TUMOR ACTIVITY OF FLAVONOIDS ON NK-LY ASCITES TUMOR-CELLS
    MOLNAR, J
    BELADI, I
    DOMONKOS, K
    FOLDEAK, S
    BODA, K
    VECKENSTEDT, A
    NEOPLASMA, 1981, 28 (01) : 11 - 18
  • [22] Glycoengineered anti-CD39 promotes anticancer responses by depleting suppressive cells and inhibiting angiogenesis in tumor models
    Zhang, Haohai
    Feng, Lili
    Mello, Paola de Andrade
    Mao, Changchuin
    Near, Richard
    Csizmadia, Eva
    Chan, Leo Li-Ying
    Enjyoji, Keiichi
    Gao, Wenda
    Zhao, Haitao
    Robson, Simon C.
    JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (13):
  • [23] NK cell specific checkpoint inhibition improves anti-tumor efficacy of patient derived NK cells against autologous Multiple Myeloma
    Tognarelli, Sara
    Von Metzler, Ivana
    Wirsching, Sebastian
    Jakobs, Benedikt
    Mackensen, Andreas
    Serve, Hubert
    Bader, Peter
    Ullrich, Evelyn
    BONE MARROW TRANSPLANTATION, 2018, 53 : 232 - 233
  • [24] AB598, A THERAPEUTIC ANTI-HUMAN CD39 ANTIBODY, BINDS AND INHIBITS CD39 ENZYMATIC ACTIVITY IN VIVO TO PROMOTE ANTI-TUMOR IMMUNITY
    Parashar, Kaustubh
    Clor, Julie
    Anderson, Amy
    Vani, Urvi
    Singh, Jaskirat
    Stagnaro, Enzo
    Soriano, Ferdie
    Kaplan, Angelo
    Kline, Janine
    Seitz, Lisa
    Young, Stephen
    Walker, Nigel
    Walters, Matthew
    Fernandez-Salas, Ester
    Bowman, Christine
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1033 - A1033
  • [25] GPER1 Activation Exerts Anti-Tumor Activity in Multiple Myeloma
    Cantafio, Maria Eugenia Gallo
    Torcasio, Roberta
    Scionti, Francesca
    Mesuraca, Maria
    Ronchetti, Domenica
    Pistoni, Mariaelena
    Bellizzi, Dina
    Passarino, Giuseppe
    Morelli, Eugenio
    Neri, Antonino
    Viglietto, Giuseppe
    Amodio, Nicola
    CELLS, 2023, 12 (18)
  • [26] In vivo anti-tumor activity of atiprimod on SCID models of multiple myeloma.
    Neri, P
    Tassone, P
    Shammas, MA
    Batchu, RB
    Blotta, S
    Samala, S
    Catley, L
    Hamasaki, M
    Hideshima, T
    Jacob, GS
    Picker, DH
    Venuta, S
    Anderson, KC
    Munshi, NC
    BLOOD, 2005, 106 (11) : 76A - 76A
  • [27] NK Cells Characteristics and Anti-Tumor Ability In Multiple Myeloma Patients Before and After Autologous Stem Cell Transplantation
    Tognarelli, S.
    Jacobs, B.
    von Metzler, I.
    Serve, H.
    Bader, P.
    Mackensen, A.
    Ullrich, E.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S16 - S16
  • [28] A humanized anti-cd40 antibody with anti-tumor pharmacological activity and cynomolgus monkey safety
    Li, Zhenyu
    Zhao, Lili
    Zhang, Guimin
    Li, Bin
    Liu, Zhong
    Li, Guangyan
    Zhu, Zhongsong
    CANCER RESEARCH, 2023, 83 (07)
  • [29] Anti-tumor effect of dandelion flavone on multiple myeloma cells and its mechanism
    Gui, Hua
    Fan, Xiaohong
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [30] Ex vivo evaluation of the effect of regulatory T cells on the anti-tumor activity of bortezomib in multiple myeloma
    Ercetin, Ayse Pinar
    Ozcan, Mehmet Ali
    Aktas, Safiye
    Yuksel, Faize
    Solmaz, Serife Medeni
    Sevindik, Gokmen Omur
    Katgi, Abdullah
    Piskin, Ozden
    Undar, Bulent
    EXPERIMENTAL HEMATOLOGY, 2016, 44 (04) : 223 - 230
12345